Theoretical pharmacokinetic drug alterations in pediatric celiac disease

Bibliography

• Guandalini S, Assiri A. Celiac disease: a review. JAMA Pediatr 2014;168(3):272-8
   PubMed Web of Science ®Google Scholar
• Newton KP, Singer SA. Celiac disease in children and adolescents: special considerations. Semin Immunopathol 2012;34:479-96
   PubMed Web of Science ®Google Scholar
• Sapone A, Bai JC, Ciacci C, et al. Spectrum of gluten-related disorders: consensus on new nomenclature and classification. BMC Med 2012;10:13
   PubMed Web of Science ®Google Scholar
• Bai JC, Fried M, Corazza GR, et al. World Gastroenterology Organisation global guidelines on celiac disease. J Clin Gastroenterol 2013;47(2):121-6
   PubMed Web of Science ®Google Scholar
• Hoffenberg EJ, MacKenzie T, Barriga KJ, et al. A prospective study of the incidence of childhood celiac disease. J Pediatr 2003;143(3):308-14
   PubMed Web of Science ®Google Scholar
• White LE, Merrick VM, Bannerman E, et al. The rising incidence of celiac disease in Scotland. Pediatrics 2013;132(4):e924-31
   PubMed Web of Science ®Google Scholar
• Husby S, Koletzko S, Korponay-Szabó IR, et al. European Society for Pediatric Gastroenterology, Hepatology, and Nutrition guidelines for the diagnosis of coeliac disease. J Pediatr Gastroenterol Nutr 2012;54(1):136-60
   PubMed Web of Science ®Google Scholar
• Green PH, Cellier C. Celiac disease. N Engl J Med 2007;357(17):1731-43
   PubMed Web of Science ®Google Scholar
• Jatla M, Pierly PA, Hlywiak K, et al. Overview of celiac disease: Differences between children and adults. Pract Gastroenterol 2008;32(4):18-34
   Google Scholar
• Oberhuber G, Granditsch G, Vogelsang H. The hisotopathology of celiac disease; time for a standardized report scheme for pathologists. Eur J Gastroenterol Hepatol 1999;11:1184-5
   Web of Science ®Google Scholar
• Ludvigsson JF, Leffler DA, Bai JC, et al. The Oslo definitions for celiac disease and related terms. Gut 2013;62:43-52
   PubMed Web of Science ®Google Scholar
• Murch S, Jenkins H, Auth M, et al. BSPGHAN. Joint BSPGHAN and Coeliac UK guidelines for the diagnosis and management of coeliac disease in children. Arch Dis Child 2013;98(10):806-11
   PubMed Web of Science ®Google Scholar
• Sapone A, Bai JC, Ciacci C, et al. Spectrum of gluten-related disorders: consensus on new nomenclature and classification. BMC Med 2012;10:13
   PubMed Web of Science ®Google Scholar
• Bartelink I, Rademaker C, Schobben A, van den anker N. Guidelines on paediatric dosing on the basis physiology and pharmacokinetic considerations. Clin pharmacokinet 2006;45(11):1077-97
   PubMed Web of Science ®Google Scholar
• Sage DP, Kulczar C, Roth W, et al. Persistent pharmacokinetic challenges to pediatric drug development Frontiers in genetics. 2014;28:1-7
   Google Scholar
• Yokoi T. Essentials for starting a pediatric clinical study: Pharmacokinetics in children. J Toxicol Sci 2009;34(Suppl 2):SP307-12
   PubMed Web of Science ®Google Scholar
• En Y, Nuttall JJ, Egbers C, et al. High prevalence of subtherapeutic plasma concentrations of efavirenz in children. J Acquir Immune Defic Syndr 2007;45(2):133-6
   PubMed Web of Science ®Google Scholar
• de Wildt SN, Tibboel D, Leeder JS. Drug metabolism for the paediatrician. Arch Dis Child 2014;99(12):1137-42
   PubMed Web of Science ®Google Scholar
• Maples HD, James LP, Stowe CD. Special Pharmacokinetic and Pharmacodynamic consideration is children. In: Burton ME, Shaw L, Schentag J, Evans W, editors. Applied Pharmacokinetics & pharmacodynamics: Principles of Therapeutic Drug Monitoring.4th edition. Lippincott Williams & Wilkins, Baltimore, MD, USA; 2006; p. 213-25
   Google Scholar
• Kearns GL, Abdel-Rahman SM, Alander SW, et al. Developmental pharmacology-drug disposition, action and therapy in infants and children. N Eng J Med 2003;349:1157-67
   PubMed Web of Science ®Google Scholar
• Washington N, Spensley PJ, Smith CA, et al. Dual pH probe monitoring versus single pH probe monitoring in infants on milk feeds: the impact on diagnosis. Arch Dis Child 1999;81:309-12
   PubMed Web of Science ®Google Scholar
• Mooij MG, de Koning BA, Huijsman ML, de Wildt SN. Ontogeny of oral drug absorption processes in children. Expert Opin Drug Metab Toxicol 2012;8(10):1293-303
   PubMed Web of Science ®Google Scholar
• Strolin B, Baltes EL. Drug metabolism and disposition in children. Fundam Clin Pharmacol 2003;17:281-99
   PubMed Web of Science ®Google Scholar
• Siegel M, Lebenthal E, Krantz B. Effect of caloric density on gastric emptying in premature infants. J pediatr 1984;104(1):118-22
   PubMed Web of Science ®Google Scholar
• Husband J, Husband P. Gastric emptying of water and glucose solutions in the new born. Lancet 1969;2:409-11
   PubMed Web of Science ®Google Scholar
• Dumont RC, Rudolph CD. Development of gastrointestinal motility in the infant and child. Gastroenterol Clin Nor Am 1994;23:655-71
   PubMed Web of Science ®Google Scholar
• Sage DP, Kulczar C, Roth W, et al. Persistent pharmacokinetic challenges to pediatric drug development. Front Genet 2014;28:1-7
   Google Scholar
• de Wildt SN, Kearns GL, Leeder JS, et al. Cytochrome P450 3A ontogeny and drug disposition. Clin Pharmacokinet 1999;37(6):485-506
   PubMed Web of Science ®Google Scholar
• McLeod HI, Relling MV, Crom WR, et al. Disposition of antineoplastic agents in the very young child: pharmacokinetics in children Br J Cancer Suppl. 1992;18:S23-9
   Google Scholar
• Pacifici GM, Viani A, Taddeucci-Brunelli G, et al. Effects of development, aging and renal and hepatic insufficiency as well as hemodialysis on the plasma concentration of albumin and alpha acid glycoprotein; implication for binding of drugs. Ther Drug Monit 1986;8(3):259-63
   PubMed Web of Science ®Google Scholar
• Notarianni LJ. Plasma protein binding of drugs in pregnancy and in neonates. Clin Pharmacokinet 1990;18:20-36
   PubMed Web of Science ®Google Scholar
• Boucher FD, Modlin JF, Well S, et al. Phase I evaluation of zidovudine administered in infants exposed at birth to the human immunodeficiency virus. J Pediatr 1993;122:1137-44
   Web of Science ®Google Scholar
• Scuhuetz JD, Beach DL, Guzelian PS. Selective expression cytochrome P450 CYP3A mRNAs in embroyonic and adult human liver. Pharmacogenteitics 1994;4(1):11-20
   PubMedGoogle Scholar
• Miyagi S, Milne M, Coughtrie M, et al. Neonatal development of hepatic UGT1A9: Implications of pediatric pharmacokinetics. Drug Metab Dispos 2012;40(7):1321-7
   PubMed Web of Science ®Google Scholar
• Miyagi S, Collier A. The development of UDP-glucuronsyltransferases 1A1 and 1A6 in the pediatric liver. Drug Metab Dispos 2011;39(5):912-19
   PubMed Web of Science ®Google Scholar
• Sweeney DE, Vallon V, Rieg T, et al. Functional maturation of drug transporters in the developing, neonatal, and postnatal kidney. Mol Pharmacol 2011;80(1):147-54
   PubMed Web of Science ®Google Scholar
• Funk RS, Brown JT, Abdel-Rahman SM. Pediatric pharmacokinetics: human development and drug disposition. Pediatr Clin North Am 2012;59(5):1001-16
   PubMed Web of Science ®Google Scholar
• Morselli PL. Clinical pharmacology of the perinatal period and early infancy. Clin Pharmacokinet 1989;17(suppl 1):13-28
   PubMed Web of Science ®Google Scholar
• Arant BS. Developmental patterns of renal functional maturation compared in the human neonate. J Pediatr 1978;92(5):705-12
   PubMed Web of Science ®Google Scholar
• Loughnan PM, Sitar DS, Ogilvie RI, et al. Pharmacokinetic analysis of the disposition of intravenous theophylline in young children. J Pediatr 1976;88(5):874-9
   PubMed Web of Science ®Google Scholar
• Grygiel JJ, Ward H, Ogborne M, et al. Relationships between plasma theophylline clearance, liver volume and body weight in children and adults. Eur J Clin Pharmacol 1983;24(4):529-32
   PubMed Web of Science ®Google Scholar
• Tran TH, Smith C, Mangione RA. Drug absorption in celiac disease. Am J Health Syst Pharm 2013;70(24):2199-206
   PubMed Web of Science ®Google Scholar
• Sandle GI, Ward A, Rawlins MD, Record CO. Propranolol absorption in untreated coeliac disease. Clin Sci (Lond) 1982;63(1):81-5
   PubMed Web of Science ®Google Scholar
• Kitis G, Lucas ML, Bishop H, et al. Altered jejunal surface pH in coeliac disease: its effect on propranolol and folic acid absorption. Clin Sci (Lond) 1982;63(4):373-803
   PubMed Web of Science ®Google Scholar
• Parsons RL, Kaye CM, Raymond K, et al. Absorption of propranolol and practolol in Coeliac disease. Gut 1976;17(2):139-43
   PubMed Web of Science ®Google Scholar
• Parsons RL, Hossack G, Paddock G. The absorption of antibiotics in adult patients with celiac disease. J Antimicrob Chemother 1975;1(1):39-50
   PubMedGoogle Scholar
• Parsons RL, Kaye CM, Raymond K. Pharmacokinetics of salicylate and indomethacin in coeliac disease. Eur J Clin Pharmacol 1977;11(6):473-7
   PubMed Web of Science ®Google Scholar
• Holt S, Heading RC, Clements JA, et al. Acetaminophen absorption and metabolism in celiac disease and Crohn’s disease. Clin Pharmacol Ther 1981;30:232-8
   PubMed Web of Science ®Google Scholar
• Prybys KM. Deadly drug interactions in emergency medicine. Emerg Med Clin North Am 2004;22:845-63
   PubMed Web of Science ®Google Scholar
• Lang CC, Brown RM, Kinirons MT, et al. Decreased intestinal CYP3A in celiac disease: reversal after successful gluten-free diet: a potential source of interindividual variability in first-pass drug metabolism. Clin Pharmacol Ther 1996;59(1):41-6
   PubMed Web of Science ®Google Scholar
• Morón B, Verma AK, Das P, et al. CYP3A4-catalyzed simvastatin metabolism as a non-invasive marker of small intestinal health in celiac disease. Am J Gastroenterol 2013;108(8):1344-51
   PubMed Web of Science ®Google Scholar
• Johnson TN, Tanner MS, Taylor CJ, Tucker GT. Enterocytic CYP3A4 in a paediatric population: developmental changes and the effect of coeliac disease and cystic fibrosis. Br J Clin Pharmacol 2001;51(5):451-60
   PubMed Web of Science ®Google Scholar
• Holmes GK. Celiac disease and malignancy. J Pediatr Gastroenterol Nutr 1997;24(5):S20-3
   PubMed Web of Science ®Google Scholar
• Gemer O, Zaltztein E, Gorodischer R. Absorption of orally administered gentamicin in infants with diarrhea. Pediatr Pharmacol 1983;3:119-23
   PubMedGoogle Scholar
• Heizer WD, Smith TW, Goldfinger SE. Absorption of digoxin in patients with malabsorption syndromes. Pediatr Pharmacol N Engl J Med 1971;285:257-9
   Google Scholar
• Oshikoya KA, Senbanjo IO. Pathophysiological changes that affect drug disposition in protein-energy malnourished children. Nutr Metab (Lond) 2009;6:50
   PubMed Web of Science ®Google Scholar
• Oshikoya KA, Sammons HM, Choonara I. A systematic review of pharmacokinetics studies in children with protein-energy malnutrition. Eur J Clin Pharmacol 2010;66(10):1025-35
   PubMed Web of Science ®Google Scholar
• Bano G, Raina RK, Sharma DB. Pharmacokinetics of carbamazepine in protein energy malnutrition. Pharmacology 1986;32(4):232-6
   PubMed Web of Science ®Google Scholar
• Walker O, Dawodu AH, Salako LA, et al. Single dose disposition of chloroquine in kwashiorkor and normal children--evidence for decreased absorption in kwashiorkor. Br J Clin Pharmacol 1987;23(4):467-72
   PubMed Web of Science ®Google Scholar
• Tegretol® (carbamazepine) [package insert]. Novartis; East Hanover: NJ: 2014
   Google Scholar
• Bertilsson L. Clinical pharmacokinetics of carbamazepine. Clin Pharmacokinet 1978;3(2):128-43
   PubMed Web of Science ®Google Scholar
• Chloroquine phosphate [package insert]. West-ward Pharmaceutical; Eatontown: NJ: 2010
   Google Scholar
• Eriksson M, Paalzow L, Bolme P, Mariam TW. Chloramphenicol pharmacokinetics in Ethiopian children of differing nutritional status. Eur J Clin Pharmacol 1983;24(6):819-23
   PubMed Web of Science ®Google Scholar
• Determination That CHLOROMYCETIN (Chloramphenicol) Capsules, 250 Milligrams, Were Withdrawn From Sale for Reasons of Safety or Effectiveness. Federal Register, the Daily Journal of the United States Government. Available from: https://federalregister.gov/a/2012-17091 [Last Accessed 31 May 2015]
   Google Scholar
• Kuloğlu Z, Kirsaçlioğlu CT, Kansu A, et al. Celiac disease: presentation of 109 children. Yonsei Med J 2009;50(5):617-23
   PubMed Web of Science ®Google Scholar
• Palabykoglu M, Botoman VA, Coban S, et al. A tale of two cities: typical celiac sprue presenting symptoms are significantly more common in Turkish than in US Patients. J Clin Gastroenterol 2008;42(1):62-5
   PubMed Web of Science ®Google Scholar
• Lionetti E, Francavilla R, Pavone P, et al. The neurology of coeliac disease in childhood: what is the evidence? A systematic review and meta-analysis. Dev Med Child Neurol 2010;52(8):700-7
   PubMed Web of Science ®Google Scholar
• Leroy S, Isapof A, Fargue S, et al. Tacrolimus nephrotoxicity: beware of the association of diarrhea, drug interaction and pharmacogenetics. Pediatr Nephrol 2010;25(5):965-9
   PubMed Web of Science ®Google Scholar
• Chai G, Governale L, McMahon AW, et al. Trends of outpatient prescription drug utilization in US children, 2002-2010. Pediatrics 2012;130(1):23-31
   PubMed Web of Science ®Google Scholar
• Fakhoury M, Lecordier J, Medard Y, et al. Impact of inflammation on the duodenal mRNA expression of CYP3A and P-glycoprotein in children with Crohn’s disease. Inflamm Bowel Dis 2006;12(8):745-9
   PubMed Web of Science ®Google Scholar
• Elfström P, Montgomery SM, Kämpe O, et al. Risk of thyroid disease in individuals with celiac disease. J Clin Endocrinol Metab 2008;93(10):3915-21
   PubMed Web of Science ®Google Scholar
• Stazi AV, Trinti B. Selenium status and over-expression of interleukin-15 in celiac disease and autoimmune thyroid diseases. Ann Ist Super Sanita 2010;46(4):389-99
   PubMed Web of Science ®Google Scholar
• Samsel A, Seneff S. Glyphosate, pathways to modern diseases II: Celiac sprue and gluten intolerance. Interdiscip Toxicol 2013;6(4):159-84
   PubMedGoogle Scholar
• Mitin T, Von Moltke LL, Court MH, Greenblatt DJ. Levothyroxine up-regulates P-glycoprotein independent of the pregnane X receptor. Drug Metab Dispos 2004;32(8):779-82
   PubMed Web of Science ®Google Scholar
• Collins D, Wilcox R, Nathan M, et al. Celiac disease and hypothyroidism. Am J Med 2012;125:278-82
   PubMed Web of Science ®Google Scholar
• Welander A, Prütz KG, Fored M, Ludvigsson JF. Increased risk of end-stage renal disease in individuals with coeliac disease. Gut 2012;61(1):64-8
   PubMed Web of Science ®Google Scholar
• Sahin I, Eminbeyli L, Andic S, et al. Screening for celiac disease among patients with chronic kidney disease. Ren Fail 2012;34(5):545-9
   PubMed Web of Science ®Google Scholar
• Oberhuber G, Granditsch G, Vogelsang H. The hisotopathology of celiac disease; time for a standardized report scheme for pathologists. Eur J Gastroenterol Hepatol 1999;11:1184-5
   Web of Science ®Google Scholar